Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multicenter single-arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer.
Shi Q, Qi X, Tang P, Fan L, Chen L, Wang S, Liang Y, Hu Y, Wang M, Ren L, Zhang G, Tan X, Yuan L, Du J, Wu X, Wang M, Che H, Lv P, Chen D, Hu J, Li Q, Zhang Y, Yang K, Zhong Y, Chen C, Zhou Z, Qian L, Zhang J, Ma M, Sun Y, Zhang Y, Jiang J. Shi Q, et al. Among authors: qian l. MedComm (2020). 2023 Dec 7;4(6):e435. doi: 10.1002/mco2.435. eCollection 2023 Dec. MedComm (2020). 2023. PMID: 38077249 Free PMC article.
Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.
Chen Q, Ouyang D, Anwar M, Xie N, Wang S, Fan P, Qian L, Chen G, Zhou E, Guo L, Gu X, Ding B, Yang X, Liu L, Deng C, Xiao Z, Li J, Wang Y, Zeng S, Hu J, Zhou W, Qiu B, Wang Z, Weng J, Liu M, Li Y, Tang T, Wang J, Zhang H, Dai B, Tang W, Wu T, Xiao M, Li X, Liu H, Li L, Yi W, Ouyang Q. Chen Q, et al. Among authors: qian l. Front Oncol. 2020 May 25;10:811. doi: 10.3389/fonc.2020.00811. eCollection 2020. Front Oncol. 2020. PMID: 32528890 Free PMC article.
Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data.
Anwar M, Chen Q, Ouyang D, Wang S, Xie N, Ouyang Q, Fan P, Qian L, Chen G, Zhou E, Guo L, Gu X, Ding B, Yang X, Liu L, Deng C, Xiao Z, Li J, Wang Y, Zeng S, Hu J, Zhou W, Qiu B, Wang Z, Weng J, Liu M, Li Y, Tang T, Wang J, Zhang H, Dai B, Tang W, Wu T, Xiao M, Li X, Liu H, Li L, Yi W. Anwar M, et al. Among authors: qian l. Clin Cancer Res. 2021 Aug 15;27(16):4634-4641. doi: 10.1158/1078-0432.CCR-21-0474. Epub 2021 Jun 10. Clin Cancer Res. 2021. PMID: 34112711 Free PMC article.
Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study.
Zhou M, Wang S, Wan N, Yuan S, Hu X, Zhou W, Qing B, Liu M, Sun W, Fan P, Wang J, Cao H, Xu H, Dai B, Tang P, Qian L, Zhao X, Xiao J, Zhou H, Hu J, Ding L, Tripodi D, Zdenkowski N, O'Keefe TJ, Sanchez AM, Chen L, Zhang P, Xu F. Zhou M, et al. Among authors: qian l. Ann Transl Med. 2022 Dec;10(24):1387. doi: 10.21037/atm-22-6054. Ann Transl Med. 2022. PMID: 36660637 Free PMC article.
Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.
Chen Q, Ouyang D, Anwar M, Xie N, Wang S, Fan P, Qian L, Chen G, Zhou E, Guo L, Gu X, Ding B, Yang X, Liu L, Deng C, Xiao Z, Li J, Wang Y, Zeng S, Hu J, Zhou W, Qiu B, Wang Z, Weng J, Liu M, Li Y, Tang T, Wang J, Zhang H, Dai B, Tang W, Wu T, Xiao M, Li X, Liu H, Li L, Yi W, Ouyang Q. Chen Q, et al. Among authors: qian l. Front Oncol. 2021 Mar 5;11:661128. doi: 10.3389/fonc.2021.661128. eCollection 2021. Front Oncol. 2021. PMID: 33747972 Free PMC article.
[Progress in endocrine therapy for early breast cancer].
Li P, Wu W, Qian L, Ding B, Yang M. Li P, et al. Among authors: qian l. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019 Nov 28;44(11):1268-1274. doi: 10.11817/j.issn.1672-7347.2019.190289. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019. PMID: 31919322 Free article. Chinese.
4,214 results